ADAGENE INC-ADR (ADAG) Fundamental Analysis & Valuation

NASDAQ:ADAG • US0053291078

Current stock price

3.69 USD
-0.05 (-1.34%)
At close:
3.69 USD
0 (0%)
After Hours:

This ADAG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ADAG Profitability Analysis

1.1 Basic Checks

  • ADAG had negative earnings in the past year.
  • ADAG had a negative operating cash flow in the past year.
  • In the past 5 years ADAG always reported negative net income.
  • ADAG had a negative operating cash flow in each of the past 5 years.
ADAG Yearly Net Income VS EBIT VS OCF VS FCFADAG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • ADAG has a Return On Assets of -22.50%. This is in the better half of the industry: ADAG outperforms 73.20% of its industry peers.
  • ADAG has a Return On Equity of -33.93%. This is in the better half of the industry: ADAG outperforms 71.84% of its industry peers.
Industry RankSector Rank
ROA -22.5%
ROE -33.93%
ROIC N/A
ROA(3y)-25.44%
ROA(5y)-33.48%
ROE(3y)-42.31%
ROE(5y)-53.98%
ROIC(3y)N/A
ROIC(5y)N/A
ADAG Yearly ROA, ROE, ROICADAG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • ADAG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ADAG Yearly Profit, Operating, Gross MarginsADAG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ADAG Health Analysis

2.1 Basic Checks

  • ADAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ADAG has been increased compared to 1 year ago.
  • Compared to 5 years ago, ADAG has more shares outstanding
  • ADAG has a better debt/assets ratio than last year.
ADAG Yearly Shares OutstandingADAG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ADAG Yearly Total Debt VS Total AssetsADAG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -0.34, we must say that ADAG is in the distress zone and has some risk of bankruptcy.
  • ADAG has a Altman-Z score (-0.34) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.10 indicates that ADAG is not too dependend on debt financing.
  • ADAG has a worse Debt to Equity ratio (0.10) than 63.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.34
ROIC/WACCN/A
WACC7.94%
ADAG Yearly LT Debt VS Equity VS FCFADAG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • ADAG has a Current Ratio of 3.07. This indicates that ADAG is financially healthy and has no problem in meeting its short term obligations.
  • ADAG's Current ratio of 3.07 is on the low side compared to the rest of the industry. ADAG is outperformed by 62.52% of its industry peers.
  • ADAG has a Quick Ratio of 3.07. This indicates that ADAG is financially healthy and has no problem in meeting its short term obligations.
  • ADAG's Quick ratio of 3.07 is on the low side compared to the rest of the industry. ADAG is outperformed by 60.19% of its industry peers.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 3.07
ADAG Yearly Current Assets VS Current LiabilitesADAG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ADAG Growth Analysis

3.1 Past

  • ADAG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.71%, which is quite impressive.
  • Looking at the last year, ADAG shows a very strong growth in Revenue. The Revenue has grown by 7333.04%.
  • Measured over the past years, ADAG shows a very strong growth in Revenue. The Revenue has been growing by 61.42% on average per year.
EPS 1Y (TTM)49.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.57%
Revenue 1Y (TTM)7333.04%
Revenue growth 3Y-6.18%
Revenue growth 5Y61.42%
Sales Q2Q%7333.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.92% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 27.99% on average over the next years. This is a very strong growth
EPS Next Y-0.36%
EPS Next 2Y-2.88%
EPS Next 3Y-5.13%
EPS Next 5Y12.92%
Revenue Next Year-100%
Revenue Next 2Y-23%
Revenue Next 3Y21.97%
Revenue Next 5Y27.99%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ADAG Yearly Revenue VS EstimatesADAG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2027 2028 2030 2031 2032 2033 50M 100M 150M 200M 250M
ADAG Yearly EPS VS EstimatesADAG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. ADAG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ADAG. In the last year negative earnings were reported.
  • Also next year ADAG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ADAG Price Earnings VS Forward Price EarningsADAG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ADAG Per share dataADAG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

  • A cheap valuation may be justified as ADAG's earnings are expected to decrease with -5.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.88%
EPS Next 3Y-5.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ADAG Dividend Analysis

5.1 Amount

  • ADAG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ADAG Fundamentals: All Metrics, Ratios and Statistics

ADAGENE INC-ADR

NASDAQ:ADAG (4/24/2026, 8:20:09 PM)

After market: 3.69 0 (0%)

3.69

-0.05 (-1.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-01
Earnings (Next)08-10
Inst Owners28.47%
Inst Owner Change0.05%
Ins Owners13.5%
Ins Owner Change0%
Market Cap243.81M
Revenue(TTM)7.67M
Net Income(TTM)-17.61M
Analysts83.08
Price Target11.57 (213.55%)
Short Float %0.31%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.46%
PT rev (3m)22.99%
EPS NQ rev (1m)60%
EPS NQ rev (3m)60%
EPS NY rev (1m)23.4%
EPS NY rev (3m)24.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 31.78
P/FCF N/A
P/OCF N/A
P/B 4.7
P/tB 4.7
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.12
BVpS0.79
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -22.5%
ROE -33.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.44%
ROA(5y)-33.48%
ROE(3y)-42.31%
ROE(5y)-53.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.9%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.07
Quick Ratio 3.07
Altman-Z -0.34
F-Score5
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)5.74%
Cap/Depr(5y)59.87%
Cap/Sales(3y)11.08%
Cap/Sales(5y)13.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.57%
EPS Next Y-0.36%
EPS Next 2Y-2.88%
EPS Next 3Y-5.13%
EPS Next 5Y12.92%
Revenue 1Y (TTM)7333.04%
Revenue growth 3Y-6.18%
Revenue growth 5Y61.42%
Sales Q2Q%7333.04%
Revenue Next Year-100%
Revenue Next 2Y-23%
Revenue Next 3Y21.97%
Revenue Next 5Y27.99%
EBIT growth 1Y40.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-32.16%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.28%
OCF growth 3YN/A
OCF growth 5YN/A

ADAGENE INC-ADR / ADAG Fundamental Analysis FAQ

What is the fundamental rating for ADAG stock?

ChartMill assigns a fundamental rating of 3 / 10 to ADAG.


What is the valuation status for ADAG stock?

ChartMill assigns a valuation rating of 0 / 10 to ADAGENE INC-ADR (ADAG). This can be considered as Overvalued.


How profitable is ADAGENE INC-ADR (ADAG) stock?

ADAGENE INC-ADR (ADAG) has a profitability rating of 1 / 10.


What is the financial health of ADAGENE INC-ADR (ADAG) stock?

The financial health rating of ADAGENE INC-ADR (ADAG) is 3 / 10.